Medinice (WAR:ICE) Total Debt per Share: zł0.05 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:ICE Medinice SA WAR:ICE
23 GF Score
Price zł59.90
GF Value zł0.99
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Medinice Total Debt per Share?

Medinice WAR:ICE +1.53% 23 Total Debt per Share is zł0.05 as of Jun. 2026. GuruFocus rates WAR:ICE with a GF Score™ of 23/100 and a GF Value™ of zł0.99 (Significantly Overvalued). The stock has 1 warning sign investors should review.

zł0.05 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Medinice's Total Debt Per Share for the quarter that ended in Jun. 2026 was zł0.05.


Medinice Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Medinice's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinice Total Debt per Share Chart

Medinice Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial 0.12 0.09 0.08 0.05 0.04

Medinice Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.06 0.04 0.05 0.05
WAR:ICE
23GF Score
Medinice SA WAR:ICE
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medinice Total Debt per Share Calculation

Medinice's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Medinice's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of zł0.05 mean?
Medinice (WAR:ICE) has a Total Debt per Share of zł0.05 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Medinice and its competitors.
Is Medinice's Total Debt per Share too high?
Medinice's current Total Debt per Share is zł0.05. Overall, Medinice has a GF Score™ of 23/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medinice's Total Debt per Share compare to ABT and SYK?
Medinice's Total Debt per Share of zł0.05 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Medical Devices & Instruments company?
A good Total Debt per Share depends on the Medical Devices & Instruments industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Medinice and its competitors. Medinice's current Total Debt per Share is zł0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinice stock overvalued right now?
Based on GuruFocus' analysis, Medinice (WAR:ICE) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.99, compared to a current price of zł59.90 — trading 5950.5% above its estimated fair value. The current Total Debt per Share is zł0.05. Medinice's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Medinice (WAR:ICE), the current Total Debt per Share is zł0.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medinice (WAR:ICE) Overvalued in 2026?

Based on GuruFocus' analysis, Medinice stock appears to be overvalued. The current stock price of zł59.90 is trading 5950.5% above its estimated GF Value™ of zł0.99. GuruFocus considers Medinice to be Significantly Overvalued.

Key valuation signals for WAR:ICE:

  • Total Debt per Share: zł0.05
  • GF Value™: zł0.99 vs. price of zł59.90 (5950.5% above fair value)
  • GF Score™: 23/100 with 1 warning sign

No single metric tells the full story. See the WAR:ICE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medinice Business Description

Other Exchanges 77E:Germany
Address Hankiewicza Street 2, Warszawa, POL, 02-103
Medinice SA is a Polish company operating in the MedTech industry. The company is engaged in creating, developing and commercializing solutions in the field of medicine, in particular, cardiology and cardio surgery. Its portfolio includes close around 12 projects including CathAIO, an electrode with universal diagnostic, electrophysiological, haemodinamic and biohemic functions and can be used for RF ablation; cryoapplicator, for minimally invasive cardiosurgical cryoablation; Med-iConsole allows to reduce the need to use multiple computer devices during electrophysiological treatment; Minimax and Pacepress.
23GF Score

Get the complete analysis for WAR:ICE

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł59.90
Price
zł0.99
GF Value